The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
This transformation will enable GE HealthCare to build a strong foundation for business growth
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Subscribe To Our Newsletter & Stay Updated
